Detalhe da pesquisa
1.
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
Blood
; 135(19): 1685-1695, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315407
2.
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Genes Chromosomes Cancer
; 60(7): 482-488, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611795
3.
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.
Hemasphere
; 8(3): e51, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463444
4.
High grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma.
Leuk Lymphoma
; 63(6): 1356-1362, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045798
5.
Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults.
Leukemia
; 36(11): 2577-2585, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35974102
6.
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
Genes (Basel)
; 12(8)2021 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34440292
7.
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia.
Hemasphere
; 6(11): e795, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36285071